Mazars appointed as exclusive M&A sell-side lead advisor to Simulands on capital raise

February 2023 | Simulands, a leading provider of medical simulation training equipment in the field of structural cardiac interventions, sold a minority share to SHS Capital in its latest funding round of EUR 10.0m. Simulands is thus well prepared to accelerate the commercialisation of its simulators and their education and training services in the cardiovascular field for physicians.

Mazars provided exclusive M&A sell-side lead advisory services and financial modelling services to Simulands in relation to its latest funding round of EUR 10 million in exchange for an equity stake in the company.

Simulands was advised by the financial advisory team of Mazars in Switzerland.

Want to know more?